Go Pro

Sei Investments Co. Sells 121,359 Shares of Perrigo Company plc $PRGO

Perrigo logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Sei Investments reduced its Perrigo stake by 43.3% in the first quarter, selling 121,359 shares and retaining 159,010 shares valued at approximately $1.7 million. Institutional investors collectively own 95.91% of PRGO.
  • Perrigo reported quarterly EPS of $0.50, exceeding analyst expectations of $0.39, while revenue reached $1.02 billion, down 3.1% year over year. The company issued fiscal 2026 EPS guidance of $2.25–$2.55.
  • Analysts maintain a consensus “Hold” rating with an average price target of $19.33. Perrigo also declared a quarterly dividend of $0.29 per share, representing a 9.1% annualized yield at the reported share price.
  • Five stocks we like better than Perrigo.

Sei Investments Co. lessened its stake in shares of Perrigo Company plc (NYSE:PRGO - Free Report) by 43.3% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 159,010 shares of the company's stock after selling 121,359 shares during the period. Sei Investments Co. owned 0.11% of Perrigo worth $1,708,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of PRGO. Fuller & Thaler Asset Management Inc. increased its stake in Perrigo by 291.9% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 7,824,759 shares of the company's stock valued at $108,921,000 after purchasing an additional 5,828,076 shares in the last quarter. Norges Bank acquired a new stake in shares of Perrigo in the 4th quarter valued at about $42,607,000. Invesco Ltd. grew its stake in shares of Perrigo by 134.2% in the 4th quarter. Invesco Ltd. now owns 4,542,415 shares of the company's stock valued at $63,230,000 after buying an additional 2,602,724 shares during the period. ION Fund Management Ltd bought a new stake in Perrigo in the 4th quarter valued at about $24,499,000. Finally, Vanguard Group Inc. increased its position in Perrigo by 7.9% in the 4th quarter. Vanguard Group Inc. now owns 14,983,369 shares of the company's stock valued at $208,568,000 after buying an additional 1,101,154 shares in the last quarter. 95.91% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on PRGO. Wall Street Zen upgraded Perrigo from a "hold" rating to a "buy" rating in a report on Saturday. Zacks Research upgraded shares of Perrigo from a "strong sell" rating to a "hold" rating in a report on Monday, April 27th. Finally, Weiss Ratings upgraded Perrigo from a "sell (d-)" rating to a "sell (d)" rating in a research note on Thursday. One research analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $19.33.

Check Out Our Latest Analysis on PRGO

Perrigo Price Performance

PRGO opened at $12.69 on Tuesday. The firm has a 50-day moving average price of $10.66 and a 200-day moving average price of $11.49. Perrigo Company plc has a twelve month low of $9.23 and a twelve month high of $24.60. The company has a quick ratio of 1.32, a current ratio of 2.32 and a debt-to-equity ratio of 1.31. The company has a market capitalization of $1.76 billion, a price-to-earnings ratio of -1.01, a PEG ratio of 1.46 and a beta of 0.51.

Perrigo (NYSE:PRGO - Get Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $0.50 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.39 by $0.11. Perrigo had a positive return on equity of 11.25% and a negative net margin of 41.85%.The business had revenue of $1.02 billion for the quarter, compared to analysts' expectations of $1.02 billion. During the same quarter in the prior year, the firm posted ($0.06) EPS. The firm's quarterly revenue was down 3.1% on a year-over-year basis. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. Equities analysts expect that Perrigo Company plc will post 2.2 EPS for the current year.

Perrigo Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Friday, August 28th will be given a dividend of $0.29 per share. The ex-dividend date is Friday, August 28th. This represents a $1.16 annualized dividend and a dividend yield of 9.1%. Perrigo's dividend payout ratio (DPR) is -9.27%.

Perrigo Company Profile

(Free Report)

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo's focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo's operations span research and development, manufacturing, quality assurance and global distribution.

Further Reading

Institutional Ownership by Quarter for Perrigo (NYSE:PRGO)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Perrigo Right Now?

Before you consider Perrigo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Perrigo wasn't on the list.

While Perrigo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines